Just reported
From The Cigna's results release of 5 november 2026; its quarterly report has since been filed.
Actual
US$ 73,68B
+5,6% y/y
+2,8% q/q
Guided
—
No guide given
Actual
US$ 5,47
-22% y/y
-13% q/q
Guided
—
No guide given
Actual
US$ 2,4B
-7,1% y/y
-10% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes The Cigna is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
De omzetaandelen zijn schattingen voor three months ended June 30, 2026, geen cijfers uit een ingediend rapport.
Express Scripts pharmacy benefit services
Manages prescription claims and pharmacy networks for client health plans, helps clients choose which drugs their plans cover, and negotiates drug discounts and rebates.
Accredo Specialty Pharmacy
Dispenses medicines for complex or rare conditions and provides patients with support from pharmacists, clinicians and in-home nursing services.
CuraScript SD
Supplies specialty medicines and medical products directly to hospitals, clinics and other health care providers.
Cigna employer health plans
Medical insurance and plan-administration services for employers, with options for employers that pay their employees' medical claims themselves.
International Health coverage
Health and related insurance for multinational employers, people working across borders, and employers and individuals in selected countries.
MD Live and EviCore care services
MD Live provides virtual medical and behavioral health visits; EviCore helps health plans manage coverage and care for certain medical services.
Cigna processes prescription claims and manages pharmacy networks and drug coverage for clients. It also runs home-delivery and specialty pharmacies, supplies specialty medicines to clinics and hospitals, and provides virtual care and medical care-management services. Its insurance business sells health coverage and administers employer health plans, including plans where the employer pays medical claims itself.
Gebouwd uit de eigen deponeringen van The Cigna Group bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
US$ 301,43-0,6%slot 11 nov
Cijfers tot en met 30 september 2026, uit de 10-Q ingediend op 5 november 2026
Cigna sells prescription-drug benefits and pharmacy services to employers, health plans and government programs, plus medical insurance to employers and individuals.
Grade A
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 32 kwartalen van de cijferhistorie van The Cigna Group. De andere 30 lopen terug tot februari 2019.